Pharma

J&J's pharma group quietly undergoes global overhaul

Johnson and Johnson's pharmaceutical arm is quietly undergoing a full overhaul, discontinuing numerous programs and cutting jobs across the globe.
Max Bayer , Fraiser Kansteiner Feb 3, 2023 10:36am

Teva walks away from PhRMA after similar move by AbbVie

Feb 3, 2023 4:05pm

Gilead touts growth for HIV, cancer groups amid Veklury's fall

Feb 3, 2023 1:49pm

Regeneron looks forward to launch of longer-lasting Eylea

Feb 3, 2023 12:38pm

Gilead's Trodelvy takes home key breast cancer nod

Feb 3, 2023 11:12am

It's the end of the line for Medicago's plant-based COVID shot

Feb 3, 2023 10:44am
Marketing News

Salix's first streaming TV ad for Relistor introduces MU-MAN

Feb 3, 2023 9:05am

GSK flu campaign appeals to home's chief health officer—mom

Feb 2, 2023 6:55am

Novartis delays Pluvicto filing after FDA requests more data

Feb 1, 2023 11:19am

Genentech increases visibility of Black women with MS

Feb 1, 2023 7:05am